The objective of the Administrative Core is to allow the principal investigators to focus their energies on the scientific aspects of the study plan. Recognizing that the PI is ultimately responsible for all aspects of the award, it is the aim of the administrative core to handle all non-scientific tasks that pertain to the conduct of this research. To facilitate communication, coordination and planning among the projects and the PI, Dr. Clapham will be assisted by a Laboratory/scientific-program Administrator. The PI and the Administrator will meet weekly to ensure that the PI is fully informed and an active participant in the process of Administration. The Administrative Core has three specific aims:
Aim 1 is to assist the PI and his colleagues with fiscal management ofthe award. This includes processing award notices from the NIH, managing project budgets, and assisting in the preparation of annual progress reports to the NIH. The Children's Hospital Office of Sponsored Programs (OSP) is staffed with grants management specialists who concentrate on pre-award aspects of research awards. Post-award oversight is the joint responsibility ofthe OSP and the Office of Research Finance (RFO). The Laboratory/scientific- program Administrator is responsible for daily pre- and post-award activities.
Aim 2 is to provide clerical support to the PI and his colleagues for tracking annual renewals of animal and human protocols, manuscript preparation, traveling and scheduling as it pertains to the program.
Aim 3 is to assist the PI and his colleagues in ensuring effective communication, coordination and planning for the program. The laboratory/scientific-program Administrator will schedule and facilitate monthly research update and planning meetings to be attended by each project/core leader and the PI. The internal advisory board (Corey, Yellen, Ji) will be invited on a quarterly basis to attend the research update meeting, and external advisors (Julius, Caterina, Basbaum) will be invited to attend yearly, to provide their fresh perspectives and guidance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS072040-04
Application #
8705054
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Cheng, Longzhen; Duan, Bo; Huang, Tianwen et al. (2017) Identification of spinal circuits involved in touch-evoked dynamic mechanical pain. Nat Neurosci 20:804-814
Jo, Sooyeon; Bean, Bruce P (2017) Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States. Mol Pharmacol 91:277-286
Vardeh, Daniel; Mannion, Richard J; Woolf, Clifford J (2016) Toward a Mechanism-Based Approach to Pain Diagnosis. J Pain 17:T50-69
Talbot, Sébastien; Foster, Simmie L; Woolf, Clifford J (2016) Neuroimmunity: Physiology and Pathology. Annu Rev Immunol 34:421-47
Andrews, Nick A; Latrémolière, Alban; Basbaum, Allan I et al. (2016) Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations. Pain 157:901-9
Blair, Nathaniel T; Philipson, Benjamin I; Richards, Paige M et al. (2016) Naturally Produced Defensive Alkenal Compounds Activate TRPA1. Chem Senses 41:281-92
Bourane, Steeve; Duan, Bo; Koch, Stephanie C et al. (2015) Gate control of mechanical itch by a subpopulation of spinal cord interneurons. Science 350:550-4
Talbot, Sébastien; Abdulnour, Raja-Elie E; Burkett, Patrick R et al. (2015) Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation. Neuron 87:341-54
Bean, Bruce P (2015) Pore dilation reconsidered. Nat Neurosci 18:1534-5
Brenneis, C; Kistner, K; Puopolo, M et al. (2014) Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block. Br J Pharmacol 171:438-51

Showing the most recent 10 out of 41 publications